Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy

Autor: Claus Hagen, Jørgen Hangaard, O Koldkjaer, Marianne Andersen, Ellen Grodum
Rok vydání: 1996
Předmět:
Dexamethasone/administration & dosage
Adult
Male
medicine.medical_specialty
Pituitary gland
endocrine system
Periodicity
Thyrotropin/blood
Triiodothyronine/blood
Hydrocortisone
medicine.drug_class
Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
Thyrotropin-releasing hormone
Thyrotropin
Biochemistry
Dexamethasone
Thyroxine/blood
Endocrinology
TRH stimulation test
Addison Disease
Adrenocorticotropic Hormone
Internal medicine
medicine
Humans
Hydrocortisone/administration & dosage
Glucocorticoids
Thyrotropin-Releasing Hormone
Adrenocorticotropic Hormone/blood
Addison Disease/drug therapy
business.industry
Biochemistry (medical)
Glucocorticoids/administration & dosage
Middle Aged
Circadian Rhythm
Thyroxine
medicine.anatomical_structure
Corticosteroid
Triiodothyronine
Female
business
Glucocorticoid
hormones
hormone substitutes
and hormone antagonists

medicine.drug
Blood sampling
Zdroj: Hangaard, J, Andersen, M, Grodum, E, Koldkjaer, O & Hagen, C 1996, ' Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy ', Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 7, pp. 2502-2507 . https://doi.org/10.1210/jcem.81.7.8675567
ISSN: 0021-972X
DOI: 10.1210/jcem.81.7.8675567
Popis: The inhibitory action of physiological to pathophysiological serum cortisol levels on TSH secretion were investigated in 12 patients with Addison's disease on 3 occasions. 1) In continuation of the conventional hydrocortisone (HC) substitution, a medium dose of HC (0.5 mg/kg) was infused over 23 h. 2) After 24-h withdrawal of HC, the patients had placebo infusion over 23 h. 3) After 5 days of dexamethasone (1.5 mg/day), a high dose of HC (2.0 mg/kg) was infused over 23 h. Blood sampling was performed every 10 min during the last 10 h of the study period, followed by a TRH test (10 micrograms, iv), To mimic the normal diurnal rhythm for serum cortisol, HC was infused in graduated doses, and during medium dose infusion, the serum cortisol level and the TSH pulsatility pattern were similar to those seen in normal controls. The TSH mean level was 1.0 +/- 0.5 mU/L during medium doses of HC, increasing significantly (P < 0.05) to 2.0 +/- 1.6 mU/L during the low cortisol state and was significantly (P < 0.05) suppressed to 0.4 +/- 0.2 mU/L during high doses of glucocorticoids, when the pulse frequency was also significantly reduced (P < 0.01). Together with a dose-dependent inhibitory action of glucocorticoids on the TSH response to TRH, our data indicate that even physiological serum levels of cortisol have an influence on endogenous TSH secretion, probably caused by regulation of the pituitary sensitivity to TRH.
Databáze: OpenAIRE